BLW vs HQL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high dividend yield of 9.86%, the payout ratio is alarmingly high at 97.73%, threatening sustainability. Profitability metrics are strong on paper with a 91.48% operating margin and 81.91% profit margin, but these are offset by weak liquidity (Current Ratio: 0.07) and negative revenue growth. The stock trades below its Graham Number of $20.91 and intrinsic value estimate of $41.0, suggesting potential undervaluation, but structural risks and poor technical trend (0/100) undermine this advantage.
HQL presents as a deep-value opportunity, anchored by a stable Piotroski F-Score of 6/9 and a significant valuation gap, with a current price of $17.56 trading well below its Graham Number ($33.01) and Intrinsic Value ($82.31). While the company exhibits severe operational anomalies—specifically a -69.90% revenue collapse and a deeply negative operating margin—the massive earnings growth and low P/E ratio (6.29) suggest the entity is benefiting from significant investment gains rather than core fee income. The high dividend yield of 12.76% is supported by a sustainable payout ratio, though the bearish technical trend (10/100) suggests a period of consolidation or price correction is underway.
Compare Another Pair
Related Comparisons
BLW vs HQL: Head-to-Head Comparison
This page compares BlackRock Limited Duration Income Trust (BLW) and Abrdn Life Sciences Investors (HQL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.